bbs 20102011 slide metabolisme

Upload: shiina-lee

Post on 06-Apr-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    1/19

    12/30/2012/30/20

    METABOLISMEMETABOLISME

    DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC

    UNIVERSITAS SUMATERA UTARA

    dr. Yunita Sari Pane

    Pharmacokinetic

    absorption

    distribution

    BIOTRANSFORMATIONelimination

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    2/19

    12/30/2012/30/20

    Oral

    Administration

    Intestines

    Liver

    Intravenous

    Administration

    Metabolism

    GI: BiliaryGI: Biliary--Fecal RouteFecal Route

    liverliver

    bilebile

    gall bladdergall bladder

    GI trackGI track

    bloodblood

    Enterohepatic cycleEnterohepatic cycle

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    3/19

    12/30/2012/30/20

    GI: BiliaryGI: Biliary--Fecal RouteFecal Route

    lipid soluble drugs have prolongedlipid soluble drugs have prolongedeffectseffects

    Oral DrugsOral Drugs

    enter stomachenter stomach: highly acidic: highly acidic

    environmentenvironment

    absorbed by GI tract into portalabsorbed by GI tract into portalcirculation of the livercirculation of the liver

    firstfirst--pass effectpass effect

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    4/19

    12/30/2012/30/20

    First Pass EffectFirst Pass Effect

    pass throughpass throughliver beforeliver beforereachingreachingcirculationcirculation

    undergoundergo

    metabolismmetabolismby liverby liver

    BiotransformationBiotransformation

    chemical alteration of drugchemical alteration of drug

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    5/19

    12/30/2012/30/20

    BiotransformationBiotransformation

    changechange

    sizesize

    lipid solubilitylipid solubility

    charge or polaritycharge or polarity

    Sites of biotransformationSites of biotransformation

    liver: greatest activityliver: greatest activity

    othersothers

    intestines, kidneys, brain, &intestines, kidneys, brain, &plasmaplasma

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    6/19

    12/30/2012/30/20

    Factors AffectingFactors Affecting

    BiotransformationBiotransformation

    AgeAge

    very youngvery young

    less developed enzyme systemless developed enzyme system

    less developed blood brainless developed blood brainbarrierbarrier

    very oldvery old decreased GI absorptiondecreased GI absorption

    decreased renal clearancedecreased renal clearance

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    7/19

    12/30/2012/30/20

    DiseaseDisease

    altered liver enzymesaltered liver enzymes

    liver diseaseliver disease

    most decrease enzymesmost decrease enzymes

    some may increasesome may increase

    DiseaseDisease

    other diseases that decreasedother diseases that decreasedliver enzymesliver enzymes

    hypothyroidhypothyroid

    hypoxemiahypoxemia

    malnutritionmalnutrition

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    8/19

    12/30/2012/30/20

    OtherOther

    genetic alterations or defects ingenetic alterations or defects inenzymesenzymes

    metabolize drug more slowly ormetabolize drug more slowly ormore rapidlymore rapidly

    BiotransformationBiotransformation

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    9/19

    12/30/2012/30/20

    Decreased Activity of Liver EnzymesDecreased Activity of Liver Enzymes

    decreased rate of biotransformationdecreased rate of biotransformation

    can result in toxic effects

    MetabolismMetabolism

    (Biotransformation)(Biotransformation)

    Two effectsTwo effects

    Transformation to less activeTransformation to less activemetabolitemetabolite

    Enhancement of solubilityEnhancement of solubility

    Liver = primary siteLiver = primary site Liver diseaseLiver disease

    Slows metabolismSlows metabolism

    Prolongs effectsProlongs effects

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    10/19

    12/30/2012/30/20

    Hepatic FirstHepatic First--PassPass

    MetabolismMetabolism

    Affects orally administered drugsAffects orally administered drugs

    Metabolism of drug by liverMetabolism of drug by liverbefore drug reaches systemicbefore drug reaches systemiccirculationcirculation

    Drug absorbed into portalDrug absorbed into portalcirculation, must pass throughcirculation, must pass throughliver to reach systemic circulationliver to reach systemic circulation

    May reduce availability of drugMay reduce availability of drug

    EliminationElimination

    Elimination

    Drug Metabolism

    (Biotransformation)

    Excretion

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    11/19

    12/30/2012/30/20

    Drug MetabolismDrug Metabolism

    The chemical modification of drugsThe chemical modification of drugswith the overall goal of getting ridwith the overall goal of getting ridof the drugof the drug

    Enzymes are typically involved inEnzymes are typically involved inmetabolismmetabolism

    DrugMetabolism More polar

    (water soluble)

    Drug

    Excretion

    ABSORPTION METABOLISM ELIMINATIONABSORPTION METABOLISM ELIMINATION

    Phase I Phase IIPhase I Phase II

    DrugDrug ConjugateConjugate

    Drug metabolite with ConjugateDrug metabolite with Conjugatemodified activitymodified activity

    DrugDrug

    Inactive drug ConjugateInactive drug Conjugatemetabolitemetabolite

    DrugDrug

    LipophilicLipophilic HydrophilicHydrophilic

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    12/19

    12/30/2012/30/20

    METABOLISM REACTIONMETABOLISM REACTION

    I. PHASEI. PHASE -- II

    -- Oxidation : Morphin,Oxidation : Morphin,

    acetaminophenacetaminophen

    -- Reduction : Chloramphenicol,Reduction : Chloramphenicol,

    ClonazepamClonazepam

    -- Hydrolisis : Aspirin, LidocainHydrolisis : Aspirin, Lidocain

    METABOLISM REACTIONMETABOLISM REACTION

    II. PHASEII. PHASE-- IIII

    -- Conjugation : MorphinConjugation : Morphin

    (process glucuroridation),(process glucuroridation),

    INH (process acetilation),INH (process acetilation),

    etc.etc.

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    13/19

    12/30/2012/30/20

    Sites of Drug MetabolismSites of Drug Metabolism

    Metabolism occurs in manyMetabolism occurs in manytissuestissues

    E.g. brain, kidney, lungE.g. brain, kidney, lung

    But mostly in the liver because But mostly in the liver because

    all of the blood in the bodyall of the blood in the body

    passes through the liver.passes through the liver.

    Consequences Of MetabolismConsequences Of Metabolism

    Drug metabolism != DrugDrug metabolism != Druginactivationinactivation

    The metabolite may haveThe metabolite may have

    EqualEqual activityactivity to the drugto the drug

    NoNo oror reducedreduced activityactivity IncreasedIncreased activity (Prodrugs)activity (Prodrugs)

    ToxicToxic propertiesproperties

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    14/19

    12/30/2012/30/20

    METABOLISM KINETICMETABOLISM KINETIC

    1.First order kinetic1.First order kinetic

    if drugs lower dosesif drugs lower doses

    metabolism rapidly.metabolism rapidly.

    2.Zerro order kinetic2.Zerro order kinetic

    if drugs higher dosesif drugs higher doses

    metabolism slowly.metabolism slowly.

    The Most Important EnzymesThe Most Important Enzymes

    Microsomal cytochrome P450Microsomal cytochrome P450monooxygenase family of enzymes,monooxygenase family of enzymes,which oxidize drugswhich oxidize drugs

    Act onAct on structurally unrelatedstructurally unrelated drugsdrugs

    Metabolize theMetabolize the widestwidest range ofrange ofdrugs.drugs.

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    15/19

    12/30/2012/30/20

    Alteration in first pass metabolismAlteration in first pass metabolism

    (note: high clearance(note: high clearancedrug have > 30%drug have > 30%extraction from hepaticextraction from hepaticblood (F < 0.7))blood (F < 0.7))

    a drug that inhibitsa drug that inhibitshepatic metabolism willhepatic metabolism willincrease bioavailability ofincrease bioavailability ofhigh clearance drughigh clearance drug(provided it is(provided it is

    metabolised by themetabolised by theenzyme(s) inhibited) andenzyme(s) inhibited) andvicevice--versaversa

    Examples:Examples:

    cimetidine inhibits CYP450s,cimetidine inhibits CYP450s,therefore doubles oraltherefore doubles oralpropranolol bioavailabilitypropranolol bioavailability

    phenytoin induces enzymes,phenytoin induces enzymes,therefore decreases felodipinetherefore decreases felodipinebioavailabilitybioavailability

    acute alcohol intake inhibits aacute alcohol intake inhibits aCYP, therefore amitriptilineCYP, therefore amitriptilinebioavailability is higherbioavailability is higher

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    16/19

    12/30/2012/30/20

    Enzyme InhibitionEnzyme Inhibition

    (drugs that reduce hepatic blood flow(drugs that reduce hepatic blood flowalso inhibit metabolism of highalso inhibit metabolism of highclearance drugs)clearance drugs)

    if this metabolic route is a majorif this metabolic route is a majorpathway of elimination, drug kineticspathway of elimination, drug kineticswill change (increase Css and T(1/2))will change (increase Css and T(1/2))and therefore drug response willand therefore drug response willchangechange

    enzyme inhibition is immediate, and onenzyme inhibition is immediate, and oncessation of inhibitor, reversion tocessation of inhibitor, reversion tonormal is immediatenormal is immediate

    examples:examples:

    metronidazole decreasesmetronidazole decreasesclearance of warfarin by 40%clearance of warfarin by 40%

    cimetidine decreases clearancecimetidine decreases clearanceof phenytoin by 35%of phenytoin by 35%

    propranolo decreases clearancepropranolo decreases clearanceof lignocaine by 50% (byof lignocaine by 50% (byreducing hepatic blood flow)reducing hepatic blood flow)

    omeprazole decreases clearanceomeprazole decreases clearanceof warfarinof warfarin

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    17/19

    12/30/2012/30/20

    examples with regards to enzymes otherexamples with regards to enzymes other

    than cytochrome P450sthan cytochrome P450s

    example 1:example 1:allopurinolallopurinol

    is a xanthine oxidase inhibitoris a xanthine oxidase inhibitor(used as an anti(used as an anti--gout agent)gout agent)

    also inhibits metabolism ofalso inhibits metabolism ofcytotoxic agent 6cytotoxic agent 6--mercaptopurine (6mercaptopurine (6--MP)MP)

    therefore concurrent use oftherefore concurrent use of

    allopurinol and 6allopurinol and 6--MP leads toMP leads toelevated plasma levels of 6elevated plasma levels of 6--MPMPand toxicityand toxicity

    example 2:example 2:disulfiramdisulfiram

    inhibits aldehydeinhibits aldehydedehydrogenasedehydrogenase

    therefore is used to givetherefore is used to givealcoholics a nasty "aldehydealcoholics a nasty "aldehyde

    reaction" when they takereaction" when they takealcoholalcohol

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    18/19

    12/30/2012/30/20

    Alteration of liver blood flow:Alteration of liver blood flow:

    for high first pass clearancefor high first pass clearancedrugs only, a fall in liver blooddrugs only, a fall in liver bloodflow will cause a clear reductionflow will cause a clear reductionin systemic clearancein systemic clearance

    example:example:lignocaine toxicity canlignocaine toxicity canoccur when patients are given aoccur when patients are given a

    betabeta--blocker which reducesblocker which reducesliver blood flowliver blood flow

    ImportanceImportance

    Toxic drugs may accumulateToxic drugs may accumulate

    Useful drugs may have noUseful drugs may have nobenefit because doses are toobenefit because doses are toosmall to establish therapysmall to establish therapy

    A drug can be rapidlyA drug can be rapidlymetabolized.metabolized.

  • 8/3/2019 Bbs 20102011 Slide Metabolisme

    19/19

    12/30/2012/30/20